Medicare Enrolled

Dr. Roberto Mixco, MD

Neurology · Merritt Island, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1395 N COURTENAY PKWY, Merritt Island, FL 32953
3214521224
In practice since 2006 (19 years)
NPI: 1396805255 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mixco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mixco? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mixco

Dr. Roberto Mixco is a neurology specialist in Merritt Island, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mixco performed 1,240 Medicare services across 816 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mixco received a total of $17,511 from 59 pharmaceutical and/or device companies across 781 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mixco is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 27% volume in FL $17,511 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,240
Medicare services
Top 27% in FL for neurology
816
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~65 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 382 $90 $200
Office visit, established patient (20-29 min) 259 $62 $150
Office visit, established patient, complex (40-54 min) 180 $129 $250
Needle measurement of electrical activity in arm or leg muscles, complete study 149 $73 $150
New patient office visit (45-59 min) 86 $123 $260
Measurement of brain wave activity (eeg), awake and drowsy 56 $285 $500
Nerve conduction, 5-6 studies 50 $102 $780
New patient office visit (30-44 min) 31 $77 $210
Nerve conduction, 7-8 studies 22 $129 $1,040
New patient office visit, complex (60-74 min) 13 $172 $285
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes 12 $211 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,511
Total received (2018-2024)
Avg $2,502/year across 7 years
Top 18% in FL for neurology
59
Companies
781
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,415 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$95 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,921
2023
$2,019
2022
$3,741
2021
$1,504
2020
$1,398
2019
$2,606
2018
$2,322

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$3,827
Biogen, Inc.
$1,182
UCB, Inc.
$962
Novartis Pharmaceuticals Corporation
$940
ABBVIE INC.
$795
EMD Serono, Inc.
$717
Medtronic USA, Inc.
$675
Teva Pharmaceuticals USA, Inc.
$628
SK Life Science, Inc.
$627
Eisai Inc.
$621
GENZYME CORPORATION
$559
Lilly USA, LLC
$539
Amgen Inc.
$370
Celgene Corporation
$348
Kyowa Kirin, Inc.
$322
MITSUBISHI TANABE PHARMA AMERICA, INC.
$257
Avanir Pharmaceuticals, Inc.
$251
CSL Behring
$234
ACADIA Pharmaceuticals Inc
$228
EISAI INC.
$226
Alexion Pharmaceuticals, Inc.
$223
Sunovion Pharmaceuticals Inc.
$216
Allergan, Inc.
$204
E.R. Squibb & Sons, L.L.C.
$181
Biohaven Pharmaceutical Holding Company Ltd.
$166
Janssen Pharmaceuticals, Inc
$160
PFIZER INC.
$156
Otsuka America Pharmaceutical, Inc.
$153
UPSHER-SMITH LABORATORIES LLC
$127
Mallinckrodt LLC
$114
Grifols USA, LLC
$113
Lundbeck LLC
$110
MDD US Operations, LLC
$102
Genentech USA, Inc.
$89
Upsher-Smith Laboratories LLC
$86
Acorda Therapeutics, Inc
$86
Corium, LLC
$85
Neurelis, Inc.
$84
CATALYST PHARMACEUTICALS, INC.
$70
Allergan Inc.
$69
AbbVie Inc.
$67
Mallinckrodt Hospital Products Inc.
$48
US WorldMeds, LLC
$46
Biohaven Pharmaceuticals, Inc.
$46
Supernus Pharmaceuticals, Inc.
$42
Boston Scientific Corporation
$41
Sumitomo Pharma America, Inc.
$40
Catalyst Pharmaceuticals, Inc.
$40
Microtransponder, Inc.
$39
ARGENX US, INC.
$34
Neurocrine Biosciences, Inc.
$32
IMPEL PHARMACEUTICALS INC.
$24
Mallinckrodt Enterprises LLC
$20
Abbott Laboratories
$17
Exeltis, USA Inc.
$16
Banner Life Sciences, LLC
$16
Alnylam Pharmaceuticals Inc.
$15
GE HEALTHCARE
$14
BANNER LIFE SCIENCES, LLC
$13
Top 3 companies account for 34.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · Briviact · COPAXONE · Cenobamate · DAYBUE · EMGALITY · FIRDAPSE · FYCOMPA · Fycompa · GILENYA · Gamunex-C · General - DBS · Gocovri · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · ONPATTRO · PANZYGA · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · Proclaim Family of SCS IPGs · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · Rebif · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS - Sentiva · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VUMERITY · VYEPTI · VYVGART · Vimpat · Xadago · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,412 per 100 Medicare services performed
Looking for a neurology specialist in Merritt Island?
Compare neurologists in the Merritt Island area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
12
Per 100K population
1.9
County median income
$75,817
Nearest hospital
CAPE CANAVERAL HOSPITAL
10.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mixco is a clinical cardiology specialist, with above-average Medicare volume (top 27% in FL), with low-engagement industry engagement in the top 18% of FL peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mixco experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mixco performed 382 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mixco receive payments from pharmaceutical companies?
Yes. Dr. Mixco received a total of $17,511 from 59 companies across 781 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mixco's costs compare to other neurologists in Merritt Island?
Dr. Mixco's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mixco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →